Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 162

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 162
---
 oversight, and imprisonment for individuals, as well as contractual damages and reputational harm. We could also be required to curtail or cease our operations. Any of the foregoing consequences could seriously harm our business, financial condition, results of operations or growth prospects. Our ability to offer access to telehealth services internationally is subject to the applicable laws governing remote care and the practice of medicine in the applicable jurisdiction. Each country’s interpretation and enforcement of these laws is evolving and could vary significantly. We cannot provide assurance that we have accurately interpreted each such law and regulation. Moreover, these laws and regulations may change significantly as this manner of providing products and services evolves. New or revised laws and regulations (or interpretations thereof) could have a material adverse effect on our business, financial condition, results of operations or growth prospects. 61 If we expand to the U.S., we will be subject to numerous laws and governmental regulations, and any governmental enforcement action may materially affect our financial condition and business operations. If we eventually operate in the U.S., we would be subject to regulation in the United States by both the federal government and the states in which we conduct our business, as well as in other jurisdictions outside of the United States, including: •Federal, state, and local laws regarding the use, storage, handling and disposal of medical and hazardous waste, as well as regulations relating to the safety and health of laboratory employees; •the Federal Anti -KickbackStatute and state anti -kickbackprohibitions and EKRA; •the Federal Physician Self -ReferralLaw, commonly known as the Stark Law, and the state equivalents; •the HIPAA and the CCPA including expansions and amendments pursuant to the California Privacy Rights Act; •the Medicare civil money penalty and exclusion requirements; •the Federal False Claims Act civil and criminal penalties and state equivalents; and •the FCPA, the United Kingdom Anti -BriberyAct, the GDPR and other national or provincial laws protecting personal information, the E.U. Medical Device and In Vitro Diagnostic Device Regulations, and national laws restricting industry interaction with healthcare professionals, all of which may or will apply to our international activities. The U.S. Attorney’s Offices have increased their scrutiny over the healthcare industry in recent years. The U.S. Congress, U.S. Department of Justice, Office of Inspector General of the Department of Health and Human Services, and Department of Defense have all issued subpoenas and other requests for information to conduct investigations of and commenced civil and criminal litigation against healthcare companies related to financial arrangements